← Eichor
Study identifier: NCT06468124 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Sensitivity of Organoids to Predict Treatment Outcome in Breast Cancer Metastases

Condition: Breast Neoplasms  ·  Sponsor: King's College London

PhaseN/A
Planned participants20
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of the study is to generate patient-derived organoids (PDOs) from brain resection or biopsied extra-cranial metastases. The preliminary data collected will be used to assess the ability of PDOs to predict patients' treatment response and their radio-sensitivity and chemo-sensitivity can be correlated with their survival outcome.

This description comes directly from the study's public registry record.

Talk to the study team

Anthony Kong  ·  0207 848 8302  ·  Anthony.kong@kcl.ac.uk

Christiana Cattaneo  ·  0207 848 8302  ·  christiana.1.cattaneo@kcl.ac.uk

Always discuss trial participation with your own doctor first.

Locations (2)

Guy's and St. Thomas NHS Foundation TrustLondon, United KingdomRecruiting
King's College Hospital NHS Foundation TrustLondon, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06468124